MR imaging features of medulloblastomas.
The preoperative MR studies of 25 patients with surgically proved medulloblastomas were retrospectively reviewed in order to characterize these neoplasms with regard to their MR signal intensity, size, location, and appearance after contrast enhancement. Gadopentetate dimeglumine--enhanced MR images were available in 11 patients. On short TR/short TE images, medulloblastomas generally had low to intermediate signal, and were predominantly slightly hyperintense relative to muscle and hypointense relative to white matter. On long TR/long TE images, medulloblastomas generally had intermediate to moderately high signal, predominantly hyperintense relative to muscle and white matter. Tumor signal relative to gray matter varied considerably on both short TR and long TR images. Signal heterogeneity on long TR/long TE images was observed in 91% of the lesions and resulted from intratumoral cystic zones, small blood vessels, and/or calcifications. In the patients who received gadopentetate dimeglumine, the fraction of tumor volume showing enhancement was found to be less than one third in two cases, between one third and two thirds in four cases, and greater than two thirds in five cases. The mean tumor size was 3.6 x 4.0 x 3.5 cm. The most frequent location of medulloblastoma was the mid and inferior vermis. We conclude that the unenhanced and enhanced MR characteristics of medulloblastomas are somewhat variable. Medulloblastomas should be included in the differential diagnosis when the MR findings described are present in the appropriate patient population.